Skip to main content
. Author manuscript; available in PMC: 2011 May 17.
Published in final edited form as: J Immunother. 2010 NOV-DEC;33(9):945–955. doi: 10.1097/CJI.0b013e3181f71b81

TABLE 1.

Expanded NK Cells: Culture Duration, TRAIL Expression, Viability and LCL Cells used as Feeder Cells.

Patient Expanded NK Cells Days in Culture Feeder Cells* CD56 TRAIL (MFI) Viability
1 eNK-1-1 14 LCL-1-1-D16 1,741 90

2 eNK-2-1 14 LCL-1-2-D28 1,008 86
eNK-2-2 14 LCL-1-5-D75 1,779 86
eNK-2-3 14 LCL-2-2-D29 838 84
eNK-2-4 14 LCL-3-4-D46 1,104 81

3 eNK-3-1 15 LCL-1-2-D28 860 89
eNK-3-2 14 LCL-1-5-D75 563 86
eNK-3-3 15 LCL-3-3-D43 354 89

4 eNK-4-1 16 LCL-2-1-D15 1,573 86

5 eNK-5-1 15 LCL-2-1-D15 1,460 88
eNK-5-2 15 LCL-3-2-D24 1,500 90

6 eNK-6-1 16 LCL-3-2-D24 921 91

7 eNK-7-1 14 LCL-3-5-D64 2,330 85

8 eNK-8-1 14 LCL-4-1-D69 1,394 71

LCL indicates lymphoblastoid cell line; eNK, expanded NK; D, days.

*

Corresponding feeder cells of which specimens were available.